Rare diseases
Investigational molecules
Locations
35 Cambridgepark Drive Floor 4, 02140-2325, United States
Clinical research in acute myeloid leukemia focuses on RARA-positive disease subsets, including newly diagnosed and previously untreated patients. The sponsor’s studies examine targeted treatment strategies in biomarker-defined populations with an emphasis on response outcomes and hematologic remission.
Interest extends to combination regimens involving tamibarotene with other anti-leukemic therapies, reflecting a therapeutic focus on molecularly selected AML populations.
Syros Pharmaceuticals Inc. runs clinical trials in conditions such as Acute myeloid leukaemia, Myelodysplastic syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceFrance
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
